CIK 0001177648 · Non-accelerated filer<br>Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- operating
- EIN
- 043205099
- Phone
- 617 607 0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-12 | Or Yat Sun Chief Scientific Officer | Grant or award | +5,225 | 378,267 | ||
| 2026-02-12 | Or Yat Sun Chief Scientific Officer | Shares withheld for taxes | −3,413 | $14.25 | $49K | 374,854 |
| 2026-02-12 | Luly Jay R. President and CEO | Grant or award | +4,800 | 862,826 | ||
| 2026-02-12 | Luly Jay R. President and CEO | Grant or award | +15,200 | 878,026 | ||
| 2026-02-12 | Luly Jay R. President and CEO | Shares withheld for taxes | −6,155 | $14.25 | $88K | 871,871 |
| 2025-12-05 | Capps Kathleen S. See Remarks | Sale | −323 | $14.23 | $5K | 8,377 |
| 2025-12-05 | Trout Harry R. III See Remarks | Sale | −542 | $14.23 | $8K | 16,348 |
| 2025-12-05 | Rottinghaus Scott T. Chief Medical Officer | Sale | −798 | $14.23 | $11K | 21,792 |
| 2025-12-05 | Luu Brendan Chief Business Officer | Sale | −1,394 | $14.23 | $20K | 38,329 |
| 2025-12-05 | Kieffer Tara Lynn Chief Product Strategy Officer | Sale | −2,106 | $14.23 | $30K | 30,620 |
| 2025-12-05 | Or Yat Sun Chief Scientific Officer | Sale | −2,390 | $14.23 | $34K | 371,392 |
| 2025-12-05 | Luly Jay R. President and CEO | Sale | −4,743 | $14.23 | $67K | 858,026 |
| 2025-12-02 | Capps Kathleen S. See Remarks | Sale | −207 | $13.96 | $3K | 8,700 |
| 2025-12-02 | Trout Harry R. III See Remarks | Sale | −380 | $13.96 | $5K | 16,890 |
| 2025-12-01 | Capps Kathleen S. See Remarks | Shares withheld for taxes | −85 | $14.12 | $1K | 8,907 |
| 2025-12-01 | Trout Harry R. III See Remarks | Shares withheld for taxes | −105 | $14.12 | $1K | 17,270 |
| 2025-12-01 | Luu Brendan Chief Business Officer | Shares withheld for taxes | −498 | $14.12 | $7K | 39,723 |
| 2025-12-01 | Kieffer Tara Lynn Chief Product Strategy Officer | Shares withheld for taxes | −753 | $14.12 | $11K | 32,726 |
| 2025-12-01 | Or Yat Sun Chief Scientific Officer | Shares withheld for taxes | −753 | $14.12 | $11K | 373,782 |
| 2025-12-01 | Luly Jay R. President and CEO | Shares withheld for taxes | −1,885 | $14.12 | $27K | 862,769 |
Page 2 of 7 · 135 trades